GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Other Operating Expense

Exact Therapeutics AS (OSL:EXTX) Other Operating Expense : kr25.92 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Other Operating Expense?

Exact Therapeutics AS's Other Operating Expense for the six months ended in Dec. 2023 was kr12.96 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr25.92 Mil.

Exact Therapeutics AS's quarterly Other Operating Expense increased from Dec. 2022 (kr9.19 Mil) to Jun. 2023 (kr12.96 Mil) but then declined from Jun. 2023 (kr12.96 Mil) to Dec. 2023 (kr12.96 Mil).

Exact Therapeutics AS's annual Other Operating Expense declined from Dec. 2021 (kr19.12 Mil) to Dec. 2022 (kr15.48 Mil) but then increased from Dec. 2022 (kr15.48 Mil) to Dec. 2023 (kr25.92 Mil).


Exact Therapeutics AS Other Operating Expense Historical Data

The historical data trend for Exact Therapeutics AS's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Other Operating Expense Chart

Exact Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial 0.15 15.76 19.12 15.48 25.92

Exact Therapeutics AS Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.99 6.28 9.19 12.96 12.96

Exact Therapeutics AS Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr25.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Exact Therapeutics AS Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Exact Therapeutics AS (OSL:EXTX) Business Description

Traded in Other Exchanges
N/A
Address
Ostre Aker vei 19, Oslo, NOR, 0581
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines